Dr. Daniel Roth presented his research at the annual meeting on the American Society of Retina Specialists in Boston. His presentation was entitled “Long Term Visual Acuity Response in Early Nonresponders Treated with 0.2 microgram Fluocinolone Acetonide Implants in the FAME Study”. NJRetina was the first practice in New Jersey and among the first in the nation to employ the Iluvien treatment for diabetic macular edema.
2017 Annual ASRS Meeting
Bookmark the permalink.